Alpha 2.0
Login Register
» Articles » PMID: 35342940

Risk of Gonadotoxicity with Immunotherapy and Targeted Agents Remains an Unsolved but Crucial Issue

Overview
Journal Eur J Clin Invest
Publisher Wiley
Specialty General Medicine
Date 2022 Mar 28
PMID 35342940
Authors
Matteo Lambertini
Camilla Marrocco
Stefano Spinaci
Isabelle Demeestere
Richard A Anderson
Affiliations
Soon will be listed here.
Citing Articles

The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies.

Caserta S, Cancemi G, Murdaca G, Stagno F, Di Gioacchino M, Gangemi S Biomedicines. 2024; 12(9).

PMID: 39335619 PMC: 11428457. DOI: 10.3390/biomedicines12092106.

Fertility and Pregnancy-Related Issues in Young Carriers With Breast Cancer.

Magaton I, Arecco L, Mariamidze E, Jankovic K, Stana M, Buzzatti G Breast Cancer (Auckl). 2024; 18:11782234241261429.

PMID: 38882447 PMC: 11179469. DOI: 10.1177/11782234241261429.

What are the most common controversial clinical issues in fertility preservation? A content analysis of a collaborative professional online consultation group.

Tsafrir A, BenHaroush A, Hyman J, Karavani G, Imbar T Reprod Biol Endocrinol. 2023; 21(1):77.

PMID: 37620900 PMC: 10463612. DOI: 10.1186/s12958-023-01122-5.

The future of fertility preservation for women treated with chemotherapy.

Alesi L, Nguyen Q, Stringer J, Winship A, Hutt K Reprod Fertil. 2023; .

PMID: 37068157 PMC: 10235927. DOI: 10.1530/RAF-22-0123.

The Future of Breast Cancer Research in the Survivorship Field.

Soldato D, Arecco L, Agostinetto E, Franzoi M, Mariamidze E, Begijanashvili S Oncol Ther. 2023; 11(2):199-229.

PMID: 37005952 PMC: 10260743. DOI: 10.1007/s40487-023-00225-8.